Insider · CIK 0001168218
Sigmund Rogich
Files at BIVI (BIOVIE INC.). First filing -, latest -.
In brief
Sigmund Rogich files SEC Form 4 as director at BIVI (BIOVIE INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Sigmund Rogich has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | BIVI BIOVIE INC. | AGrant or award Stock Option (right to buy)derivative | +70,000 | $0.00 | $0 | 70,000 | Jan 9, 2026 |
| Jan 5, 2026 | BIVI BIOVIE INC. | AGrant or award Stock Option (right to buy)derivative | +141,100 | $0.00 | $0 | 141,100 | Jan 9, 2026 |
| Nov 20, 2024 | BIVI BIOVIE INC. | AGrant or award Common Stock | +32,700 | $0.00 | $0 | 36,926 | Jan 7, 2025 |
| Dec 20, 2024 | BIVI BIOVIE INC. | AGrant or award Stock Option (right to buy)derivative | +22,070 | $0.00 | $0 | 22,070 | Jan 7, 2025 |
| Nov 9, 2023 | BIVI BIOVIE INC. | AGrant or award Common Stock | +42,254 | $0.00 | $0 | 42,254 | Dec 6, 2023 |
Questions about Sigmund Rogich
Answered from the filings on this page, as of the latest one.
Is Sigmund Rogich buying or selling?
Sigmund Rogich has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Sigmund Rogich's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sigmund Rogich has 0.
Where does Sigmund Rogich file Form 4?
Sigmund Rogich has filed Form 4 at BIVI (BIOVIE INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.